Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.078 | 0.7 |
mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |